CD24 and Miyoshi myopathy: Gao et al., conducted gene expression profiling of CSCs and of MM cells derived from 11 MM patients and found that CD24+ MM cells displayed features of CSCs, including self-renewal and drug resistance, suggesting these cells as a target for MM treatment (9, 146).